Mingrong Xi

6PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2023
Identification of TRPM2 as a Potential Therapeutic Target Associated with Immune Infiltration: A Comprehensive Pan-Cancer Analysis and Experimental Verification in Ovarian Cancer.

Danxi Zheng, Siyu Long, Mingrong Xi

|Apr 13, 2023
Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin.

Bowen Yang, Shanmei Yin, Zishuo Zhou

|Jul 14, 2021
The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis.

Ting Ding, Dan Tang, Mingrong Xi

|Nov 03, 2020
Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.

Yan Gao, Ting Zou, Wentong Liang

|Oct 10, 2019
Pelvic dimension as a predictor of ureteral injury in gynecological cancer surgeries.

Hui Ye, Di You, Lin Li

|Mar 10, 2018
Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: a systematic review and meta-analysis.

Hui Ye, Tiange Song, Xi Zeng

Pageof 1

Frequent Collaborators